Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D. Singhi(UPMC Health System), Ben George(Medical College of Wisconsin), Joel Greenbowe(Foundation Medicine (United States)), Jon Chung(Foundation Medicine (United States)), James Suh(Foundation Medicine (United States)), Anirban Maitra(The University of Texas MD Anderson Cancer Center), Samuel J. Klempner(Cedars-Sinai Medical Center), Andrew Hendifar(Cedars-Sinai Medical Center), Javle Milind(The University of Texas MD Anderson Cancer Center), Talia Golan(Tel Aviv University), Randall E. Brand(University of Pittsburgh Medical Center), Amer H. Zureikat(University of Pittsburgh Medical Center), Somak Roy(University of Pittsburgh Medical Center), Alexa B. Schrock(Foundation Medicine (United States)), Vincent A. Miller(Foundation Medicine (United States)), Jeffrey S. Ross(Foundation Medicine (United States)), Siraj M. Ali(Foundation Medicine (United States)), Nathan Bahary(University of Pittsburgh Medical Center)
Cited by 334Open Access
Abstract
Related Papers
A global reference for human genetic variation
Corresponding authors, Adam Auton, Gonçalo R. Abecasis et al.|Nature|2015|19.8k